Betonica Rosmarinus NDC 48951-2062

NDC codes

FDA NDC Directory

Product NDC (as listed)48951-2062Labeler and product segments. Claims need a package NDC.

Product NDC at billing width48951-2062Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
48951-2062-1	48951206201	10 AMPULE in 1 BOX (48951-2062-1) / 1 mL in 1 AMPULEMarketed from Sep 1, 2009

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Betonica Rosmarinus
Generic name (nonproprietary): betonica rosmarinus
Active ingredients: Stachys officinalis — 3 [hp_X]/mLRosmarinus officinalis flowering top — 3 [hp_X]/mL
Dosage form: Liquid
Route: Oral
Labeler: Uriel Pharmacy Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Sep 1, 2009
Listing expires: Dec 31, 2026
Identifiers: Product ID 48951-2062_2c524d29-133e-1adc-e063-6294a90a305aSPL ID 2c524d29-133e-1adc-e063-6294a90a305aSPL set ID 329763c8-92aa-4c61-9599-9ae183db239eUNII UO9989Y17N, 8JM482TI79

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N448951206201 followed by a unit qualifier and the quantity

Package 48951-2062-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 22, 2025.

Indications (excerpt from the label)

Directions: FOR ORAL USE.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)